Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 3Sarcoma, Kaposi 3Pancreatic Neoplasms 3Neoplasms 3Neoplasms, Plasma Cell 2Multiple Myeloma 2Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Acute 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Head and Neck Neoplasms 1HIV Infections 1

Interventions

pembrolizumab 2Imatinib Mesylate 2Cisplatin 2Axitinib 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2tislelizumab 1regorafenib 1gallium 68 PSMA-11 1avelumab 1Tretinoin 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Nelfinavir 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Immunotherapy 1GSK-3326595 1Everolimus 1Etoposide 1Endoscopic Mucosal Resection 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1Blood Specimen Collection 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Adenoid Cystic × Nelfinavir × Clear all
NCT01065844 2019-10-09

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

University of Iowa

Phase 2 Completed
15 enrolled 3 charts
Head & Neck

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡